Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis

BACKGROUND: Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain. METHODS: An international database of patients with OMD treated with SBRT was assembled with rigorous quality assu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuguang, Chen, Hanbo, Poon, Ian, Erler, Darby, Badellino, Serena, Biswas, Tithi, Dagan, Roi, Foote, Matthew, Louie, Alexander V., Ricardi, Umberto, Sahgal, Arjun, Redmond, Kristin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446561/
https://www.ncbi.nlm.nih.gov/pubmed/34432390
http://dx.doi.org/10.1002/cam4.4133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446561/
https://www.ncbi.nlm.nih.gov/pubmed/34432390
http://dx.doi.org/10.1002/cam4.4133

Ejemplares similares